SeaCrest Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $214K | Sell |
|
|||||
|
2025
Q1 | $289K | Sell |
|
|||||
|
2024
Q4 | $306K | Sell |
|
|||||
|
2024
Q3 | $273K | Buy |
|
|||||
|
2024
Q2 | $382K | Sell |
|
|||||
|
2024
Q1 | $423K | Sell |
|
|||||
|
2023
Q4 | $372K | Sell |
|
|||||
|
2023
Q3 | $389K | Buy |
|
|||||
|
2023
Q2 | $518K | Sell |
|
|||||
|
2023
Q1 | $462K | Buy |
|
|||||
|
2022
Q4 | $386K | Sell |
|
|||||
|
2022
Q3 | $613K | Buy |
|
|||||
|
2022
Q2 | $701K | Buy |
|
|||||
|
2022
Q1 | $862K | Sell |
|
|||||
|
2021
Q4 | $1.12M | Sell |
|
|||||
|
2021
Q3 | $995K | Buy |
|
|||||
|
2021
Q2 | $894K | Buy |
|
|||||
|
2021
Q1 | $712K | Buy |
|
|||||
|
2020
Q4 | $772K | Buy |
|
|||||
|
2020
Q3 | $580K | Sell |
|
|||||
|
2020
Q2 | $516K | Buy |
|
|||||
|
2020
Q1 | $448K | Sell |
|
|||||
|
2019
Q4 | $555K | Sell |
|
|||||
|
2019
Q3 | $526K | Buy |
|
|||||
|
2019
Q2 | $440K | Buy |
|
|||||
|
2019
Q1 | $454K | Buy |
|
|||||
|
2018
Q4 | $362K | Sell |
|
|||||
|
2018
Q3 | $557K | Sell |
|
|||||
|
2018
Q2 | $477K | Sell |
|
|||||
|
2018
Q1 | $489K | Sell |
|
|||||
|
2017
Q4 | $413K | Buy |
|